Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18858878 | 0.82 | STING1 (0.34) | STING1PDE2A | |
| SCHEMBL14001854 | 0.79 | STING1 (0.41) | STING1PDE2A | |
| SCHEMBL17928575 | 0.78 | STING1 (0.32) | STING1 | |
| SCHEMBL15045875 | 0.73 | STING1 (0.42) | STING1PDE2A | |
| SCHEMBL19370325 | 0.72 | STING1 (0.39) | STING1PDE2A | |
| SCHEMBL15257768 | 0.72 | PDE2A (0.44) | STING1PDE2A | |
| SCHEMBL24140234 | 0.70 | STING1 (0.31) | STING1 | |
| SCHEMBL14185047 | 0.67 | PDE2A (0.43) | STING1PDE2A | |
| SCHEMBL16127107 | 0.65 | PDE2A (0.40) | STING1PDE2A | |
| SCHEMBL15869925 | 0.63 | PDE2A (0.32) | PDE2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170136131-A1 | ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF | Modema Therapeutics, Inc. (US) | 2017-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170136131-A1 | ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF | NSUN2, RNGTT, NSUN3 | STING1 205/4885PDE2A 2102/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.